3 results
Until recently, most meningitis epidemics in the meningitis belt of sub-Saharan Africa were due to Neisseria meningitidis serogroup A (NmA), such that the existing WHO guidelines have been directed...
This fact sheet describes PATH’s efforts to eliminate meningococcal meningitis epidemics from Africa, once and for all. It covers work across meningitis projects, including the development and...
The WHO initiative, Market Information for Access to Vaccines (MI4A) produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies...